back to homepage
Русский

Free Communications

Thursday, June 2, 2016

Meeting Hall MOSKVA (18th floor)

Genetics & Biomarkers

11:30–12:45

Cytokine gene polymorphisms impact healthy life expectancy and coronary heart disease
V. Erdman (Russia)

Presence of cardiovascular disease and telomere length in middle‐aged and older Russians
M. Holmes (United Kingdom)

Modern estimation of hypolipidemic efficiency of inhibitors of synthesis of cholesterol by means of pharmacogenetical markers for patients by ischemic heart disease and hyperlipidemias
G. Mal (Russia)

Dynamics of subclinical carotid atherosclerosis and telomere length in ageing population
A. Ryabikov (Russia)

Gene-gene interactions affecting the risk of myocardial infarction in two populations from Russia
Y. Timasheva (Russia)

The modern concept of the atherosclerosis mechanisms: The role of the innate immunity
N. Tsygan (Russia)

Association of circulating endothelial cells and flow-dependent vasodilatation with recurrent cardiovascular events after acute myocardial infarction
A. Philippov (Russia)

New biomarkers in risk stratification of kidney injury in patients with acute coronary syndrome
I. Vishnevskaya (Ukraine)

Treatment of HLP & Familial Hypercholesterolemia & Metabolic Syndrome

14:00–15:15

Anti-inflammatory and anti-atherogenic effects of the inflammasome NLRP3 inhibitor, arglabin, in ApoE2.Ki mice fed a high fat diet
M. Rouis (France)

Hypolipidemic effects of a novel compound in an animal model of hypercholesterolemia (WHHLMI rabbits)
M. Shiomi (Japan)

Myocardial infarction regional register use for targeted screening of familial hypercholesterolemia
R. Khokhlov (Russia)

Do lipid peroxidation products contribute to atherosclerotic calcification?
S. Parthasarathy (United States)

Analysis of lipid metabolism genes variability in patients with familial hypercholesterolemia in Russia using targeted high throughput resequencing
M. Voevoda (Russia)

Incidence of hypercholesterolemia and other cardiovascular risk factors according to ESSE-RF research in West Siberia
A. Kochergina (Russia)

Aging and Diet Interactions in Atherogenesis of Nonhuman Primates
M. Wang (United States)

Metabolic Syndrome I

15:15–16:30

GQ-11: A novel PPARα agonist with beneficial effects in high fat diet-induced obesity
D. Abdalla (Brazil)

Metabolic Syndrome and Inflammatory Connective Tissue Diseases
G. Belakova (Slovakia)

The parameters of ambulatory blood pressure monitoring and endothelial dysfunction in hypertensive patients with diabetes mellitus type 2
M. Derevyanchenko (Russia)

Free but not total testosterone is inversely correlated with subclinical atherosclerosis in type 2 diabetic men
E. Faludi (Brazil)

Flow Mediated Dilatation (FMD) score as an effective tool for screening of CVD in T2DM
D. Hasnani (India)

Effectiveness of different treatment of metabolic syndrome
N. Vinogradova (Russia)

Cholesterol level or age is more powerful in subclinical atherosclerosis progression during 2-years follow-up of relatively healthy bank employers?
O. Rotar (Russia)

Biomarkers & Genetics

16:45–18:00

New peptide-based radiotracer for atherosclerosis PET imaging
D. Abdalla (Brazil)

Antibodies against C-Reactive Protein, CRP peptide and 60-Kilodalton Heat Shock Proteins in patients with Acute coronary atherothrombosis
I. Burazor (Serbia)

Lipoprotein (a) in acute coronary atherothormbosis
I. Burazor (Serbia)

Two measurements of brain natriuretic peptide levels in acute myocardial infarction improve risk prediction of recurrent events in the short-term compared to grace score: A Brasilia heart study subanalysis
L. S. Carvalho (Brazil)

Association of osteopontin level with coronary atherosclerosis and osteoporosis in man with stable coronary artery disease
V. Kashtalap (Russia)

Leukocyte telomere length in peripheral blood as ageing marker and risk factors for age-related diseases in humans
V. Maximov (Russia)

Alterations in lipid transfers to High Density Lipoprotein (HDL) in patients with Heart Failure
R. Maranhao (Brazil)

Inhibition of apoB+DGAT2 synthesis using antisense oligonucleotides rescues liver steatosis
T. Fedotova (United States)

Friday, June 3, 2016

Meeting Hall MOSKVA (18th floor)

Varia

08:30–09:45

ANITSCHKOW’S EXPANDING LEGACY: Porosity of the “Liver Sieve” influences Atherosclerosis and many other Maladies
R. Fraser (New Zealand)

Arterial stiffness in rheumatoid arthritis and coronary artery disease
L. Krougly (Russia)

Clinical features and risk factors of coronary artery diseases in rheumatoid arthritis
L. Krougly (Russia)

Immunopatological mechanisms of the destabilization of atherosclerotic plaque by human
P. Pigarevsky (Russia)

Anichkov's ideas today
E. Protasov (Russia)

Clopidogrel binds to lipoprotein-associated phospholipase A2 (Lp-PLA2) and inhibits the enzyme activity in patients with an acute coronary syndrome
A. Tselepis (Greece)

Implementation of the Treat-to-Target strategy in early rheumatoid arthritis patients could not prevent an atherosclerosis progression in carotid arteries
E. Udachkina (Russia)

Anti-Atherogenic Role of c-Kit/SCF Signaling in Hyperlipidemic Mice
R. Vazquez-Padron (United States)

“From everyday clinical practice”

09:45–11:00

The obesity-mortality paradox in the patients with peripheral artery disease undergoing lower extremity endovascular intervention
B. O. Kim (Korea)

The elderly with STEMI are more likely to have normal lipid level
A. Kochergina (Russia)

Are statins indicated for therapy of resistant hypertension? Lessons of NEMESYS study
V. Kosmalova (Slovakia)

Comparison of Multiplate analyser measurement and serum thromboxane B2 concentrations to assess the platelet response to low-dose aspirin in Chinese patients with coronary artery disease
B. Tomlinson (Hong Kong)

High incidence of asymptomatic PAD among unselected patients
C. Zara (Romania)

Elevated lipoprotein (a) (Lp (a)) levels and aggressive coronary heart disease (CHD): A casuistic approach
A. Dybvig (Hungary)

Patient-centered care for cardiovascular disease primary prevention in elderly patient
M. Gertsen (Belarus)

Absence of the posterior mitral valve leaflet detected in late adulthood
B. Kalaycı (Turkey)

Epidemiology

11:30–12:45

Long-term risk of arterial hypertension and stroke in women aged 25–64 years with sleep disturbances in Russia/Siberia: based on WHO epidemiological program MONICA-psychosocial
V. Gafarov (Russia)

Analysis of detection rate of carotid atherosclerosis in the Russian population
O. Gaisenok (Russia)

Hemodynamic parallels between erectile dyfunction and diastolic dysfuction of left ventricle
S. Krasnyak (Russia)

Diabetes Awareness Among Coronary Artery Disease Patients Differs Significantly Between Men and Women
A. Leiherer (Austria)

How important is health for young people? – The health care scales’ results among young participants of Woodstock Festival Poland
D. Maciejewska (Poland)

Carotid plaques, intima-media thickening and 10-year risk of cardiovascular outcomes and mortality in a Russian population sample
S. Malyutina (Russia)

Comparison of lipid profile of 617 professional ice hockey players with non-athletes
N. Polenova (Russia)

Current cardiovascular risk factors estimate in a representative population of Casablanca (Morocco)
R. Saile (Morocco)

Epidemiology & Cardiology/Hypertension & Varia

14:00–15:15

The low molecular weight apolipoprotein(a) phenotype as the important risk factor for coronary atherosclerosis
O. Afanasieva (Russia)

The Impact of existent cardiovascular diseases, traditional risk factors, systemic inflammation on N-Terminal pro-brain natriuretic peptide level in patients with early rheumatoid arthritis
I. Kirillova (Russia)

Notch signaling is differently altered in smooth muscle and endothelial cells of thoracic aortic aneurysm patients
D. Kostina (Russia)

Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis, results of 10-year prospective controlled single-center study
I. Gaydukova (Russia)

The causes of termination of therapy: Survey of patients of cardiological hospitals of Saratov and the small city of Saratov region
E. Naumova (Russia)

Cardiology/Hypertension

15:15–16:30

Lipid profile in patients with diabetes with a left main coronary artery stenosis
A. Galyavich (Russia)

Risk factors of coronary artery stenosis in patients with rheumatiod arthritis
E. Gerasimova (Russia)

Relationship between traditional factors of cardiovascular risk and subclinical carotid atherosclerosis
A. Golovina (Russia)

How well does the contemporary primary prevention strategy identify patients at risk: comparison with the results of carotid atherosclerosis imaging
N. Katamadze (Russia)

The influence of atorvastatin on endothelium dysfunction and combined course of ischemic heart disease, essential hypertension and chronic obstructive pulmonary disease
V. Kolomiyets (Ukraine)

The level of cardiovascular risk factors correction in patient undergoing myocardial revascularization
E. Lubinskaya (Russia)

Statins for the prevention of early postoperative cognitive dysfunction in patients undergoing coronary artery bypass grafting
O. Maleva (Russia)

Association of Pro12Ala polymorphism of PPAR-gamma2 gene with insulin resistance and coronary artery disease in Russia
E. Sergeeva (Russia)

Metabolic Syndrome II

16:45–18:00

The intensity of metabolic alterations and the results of reconstructive interventions in patients with widespread atherosclerosis
K. Khisamova (Russia)

Coronary Artery Disease as a Risk for Developing Type 2 Diabetes Mellitus
A. Leiherer (Austria)

Effect of ADAMTS5 deficiency on the metabolic syndrome
R. Lijnen (Belgium)

Relationships between lipid parameters and liver markers in men with type 2 diabetes mellitus, non-alcoholic fatty liver disease and stable ischaemic heart disease, atherosclerosis of the aorta
V. Matveev (Russia)

Metabolic syndrome complicated by coronary atherosclerosis in Arctic Circle, for example the Yakutian population: ethnicity and gender differences
A. Romanova (Russia)

Prevalence of low Testosterone among T2DM patients: symptomatic vs asymptomatic population for sexual dysfunction
B. Saboo (India)

Last update on May 23, 2016.

Symposium Secretariat
GUARANT International spol. s r. o.
Na Pankráci 17, 140 21 Prague 4
Czech Republic
Phone: +420 284 001 444
Fax: +420 284 001 448
E-mail: ias-petersburg@guarant.cz

© 2015–2016 GUARANT International